Literature DB >> 10592465

Antigen-specific, IgE-selective unresponsiveness induced by antigen-liposome conjugates. Comparison of four different conjugation methods for the coupling of antigen to liposome.

Y Nakano1, M Mori, S Nishinohara, Y Takita, S Naito, A Horino, H Kato, M Taneichi, Y Ami, Y Suzaki, K Komuro, T Uchida.   

Abstract

BACKGROUND: We have previously reported that ovalbumin (OVA) coupled with liposome via glutaraldehyde (GA) induced OVA-specific- and IgE-selective unresponsiveness in mice.
METHODS: In this study, OVA-liposome conjugates were made using four different coupling protocols: via GA, N-(6-maleimidocaproyloxy) succinimide (EMCS), disuccinimidyl suberate (DSS) and N-succimidyl-3(2-pyridyldithio)propionate (SPDP) and the induction of antigen-specific IgG and IgE antibody production was investigated for each. In addition, antigen-specific cytokine production by spleen cells of mice immunized either with OVA-liposome or with OVA adsorbed with aluminum hydroxide was investigated.
RESULTS: OVA-liposome conjugates coupled via GA or DSS did not induce anti-OVA IgE antibody production but induced substantial anti-OVA IgG antibody production. On the other hand, the induction of anti-OVA IgE unresponsiveness by OVA-liposome conjugates coupled via EMCS or SPDP was incomplete. The amount of interleukin 4 (IL-4) produced by spleen cells stimulated in vitro with OVA correlated well with anti-OVA IgE antibody production in donor mice. However, the production of no other cytokine, i.e., IL-2, IL-5, IL-10 or interferon-gamma, was correlated with in vivo IgE antibody production.
CONCLUSION: OVA-liposome coupled via GA or DSS induced complete suppression of anti-OVA IgE production. The results in this study further suggest that the regulation of IgE antibody production does not necessarily correlate with so-called Th1 cytokine production.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10592465     DOI: 10.1159/000024268

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  6 in total

Review 1.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

2.  Highly efficient antiviral CD8+ T-cell induction by peptides coupled to the surfaces of liposomes.

Authors:  Akira Takagi; Masanori Matsui; Satoshi Ohno; Hongying Duan; Osamu Moriya; Nobuharu Kobayashi; Hiroshi Oda; Masahito Mori; Akiharu Kobayashi; Maiko Taneichi; Tetsuya Uchida; Toshitaka Akatsuka
Journal:  Clin Vaccine Immunol       Date:  2009-08-12

3.  Liposome-coupled antigens are internalized by antigen-presenting cells via pinocytosis and cross-presented to CD8 T cells.

Authors:  Yuriko Tanaka; Maiko Taneichi; Michiyuki Kasai; Terutaka Kakiuchi; Tetsuya Uchida
Journal:  PLoS One       Date:  2010-12-17       Impact factor: 3.240

4.  Liposome-coupled peptides induce long-lived memory CD8 T cells without CD4 T cells.

Authors:  Maiko Taneichi; Yuriko Tanaka; Terutaka Kakiuchi; Tetsuya Uchida
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

5.  Cross-protective peptide vaccine against influenza A viruses developed in HLA-A*2402 human immunity model.

Authors:  Toru Ichihashi; Reiko Yoshida; Chihiro Sugimoto; Ayato Takada; Kiichi Kajino
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

6.  Emulsified phosphatidylserine, simple and effective peptide carrier for induction of potent epitope-specific T cell responses.

Authors:  Toru Ichihashi; Toshifumi Satoh; Chihiro Sugimoto; Kiichi Kajino
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.